The Value of Off-Patent Medicines

Off-patent medicines are key drivers for patient access for European patients. When patents expire on novel medicine products, generic versions can enter the market, where competition drives down prices and reduces costs to healthcare systems immediately.


of prescribed medicines in Europe are generic.1


of pharmaceutical expenditure is for generics.1


Generics have doubled patient access to certain treatments across Europe over the last decade.1